Showing results (621-630 of 685) with videos related to

Sort By:
Pageof 69
Heart Failure Reviews|June 25, 2014
Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidenceStephen A Hill, Ronald A Booth, P Lina Santaguida, et al.
Heart Failure Reviews|June 28, 2014
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic reviewRonald A Booth, Stephen A Hill, Andrew Don-Wauchope, et al.
Lab on a Chip|July 11, 2019
Clinical translation of microfluidic sensor devices: focus on calibration and analytical robustnessSally A N Gowers, Michelle L Rogers, Marsilea A Booth, et al.
Scientific Reports|August 3, 2019
Establishment of an RNA polymerase II-driven reverse genetics system for Nipah virus strains from Malaysia and BangladeshBryan D Griffin, Anders Leung, Mable Chan, et al.
Heart Failure Reviews|July 24, 2014
Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic reviewAndrew C Don-Wauchope, Pasqualina L Santaguida, Robert McKelvie, et al.
Heart Failure Reviews|July 24, 2014
Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic reviewPasqualina L Santaguida, Andrew C Don-Wauchope, Usman Ali, et al.
Heart Failure Reviews|July 27, 2014
BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic reviewPasqualina L Santaguida, Andrew C Don-Wauchope, Mark Oremus, et al.
The Journal of Pediatrics|January 1, 1991
Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindredsJ C Haworth, F A Booth, A E Chudley, et al.
Heart Failure Reviews|August 15, 2014
Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic reviewAndrew C Don-Wauchope, Pasqualina L Santaguida, Mark Oremus, et al.
Molecular Genetics and Metabolism|February 5, 2002
Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, CanadaC R Greenberg, A N Prasad, L A Dilling, et al.
Pageof 69